Loading...
Metformin synergizes with rapamycin to inhibit the growth of pancreatic cancer in vitro and in vivo
Previous studies have suggested that metformin may improve the survival rate of patients with pancreatic cancer (PC) by regulating the adenosine monophosphate-activated protein kinase/mammalian target of rapamycin (mTOR) signaling pathway. Rapamycin specifically targets mTOR. In the present study, t...
Saved in:
| Published in: | Oncol Lett |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
D.A. Spandidos
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5774390/ https://ncbi.nlm.nih.gov/pubmed/29434877 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.7444 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|